Cargando…

Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity

Detalles Bibliográficos
Autores principales:	Sant’Anna, Ricardo, Gallego, Pablo, Robinson, Lei Z., Pereira-Henriques, Alda, Ferreira, Nelson, Pinheiro, Francisca, Esperante, Sebastian, Pallares, Irantzu, Huertas, Oscar, Almeida, Maria Rosário, Reixach, Natàlia, Insa, Raul, Velazquez-Campoy, Adrian, Reverter, David, Reig, Núria, Ventura, Salvador
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898517/ https://www.ncbi.nlm.nih.gov/pubmed/36737445 http://dx.doi.org/10.1038/s41467-023-36239-z

Ejemplares similares

Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
por: Sant'Anna, Ricardo, et al.
Publicado: (2016)

Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation
por: Pinheiro, Francisca, et al.
Publicado: (2022)

A molecular mechanism for transthyretin amyloidogenesis
por: Yee, Ai Woon, et al.
Publicado: (2019)

Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation
por: Sant’Anna, Ricardo, et al.
Publicado: (2017)

Plasminogen activation triggers transthyretin amyloidogenesis in vitro
por: Mangione, P. Patrizia, et al.
Publicado: (2018)

Review on the Structures and Activities of Transthyretin Amyloidogenesis Inhibitors
por: Guo, Xiaohua, et al.
Publicado: (2020)

Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation
por: Esperante, Sebastián A., et al.
Publicado: (2021)

Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone’s Particle Size on Sustained Release
por: Nardi-Ricart, Anna, et al.
Publicado: (2020)

A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis
por: Marcoux, Julien, et al.
Publicado: (2015)

Santalol Isomers Inhibit Transthyretin Amyloidogenesis and Associated Pathologies in Caenorhabditis elegans
por: Mohankumar, Amirthalingam, et al.
Publicado: (2022)

Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers
por: Beklen, Hande, et al.
Publicado: (2021)

Utility of tolcapone in fluctuating Parkinson’s disease
por: Stocchi, Fabrizio, et al.
Publicado: (2006)

Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel
por: Verona, Guglielmo, et al.
Publicado: (2017)

Effects of tolcapone and bromocriptine on cognitive stability and flexibility
por: Cameron, Ian G. M., et al.
Publicado: (2018)

SOM0226, a repositioned compound for the treatment of TTR amyloidosis
por: Reig, Núria, et al.
Publicado: (2015)

The efficacy of homemade tolcapone in the treatment of patients with Parkinsons disease
por: Zhang, Pei-Lan, et al.
Publicado: (2018)

Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease
por: Casanova, Yaquelyn, et al.
Publicado: (2022)

Cofactor-mediated amyloidogenesis
por: Madine, Jillian
Publicado: (2019)

Microbiome Impact on Amyloidogenesis
por: Seira Curto, Jofre, et al.
Publicado: (2022)

The Importance of a Gatekeeper Residue on the Aggregation of Transthyretin: IMPLICATIONS FOR TRANSTHYRETIN-RELATED AMYLOIDOSES
por: Sant'Anna, Ricardo, et al.
Publicado: (2014)

Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors
por: Bhakta, Savita G, et al.
Publicado: (2017)

Modulating the Amyloidogenesis of α-Synuclein
por: Sivanesam, Kalkena, et al.
Publicado: (2016)

Transthyretin deposition promotes progression of osteoarthritis
por: Matsuzaki, Tokio, et al.
Publicado: (2017)

Quantification of Quaternary Structure Stability in Aggregation-Prone Proteins under Physiological Conditions: The Transthyretin Case
por: Robinson, Lei Z., et al.
Publicado: (2014)

Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson’s disease
por: Truong, Daniel D
Publicado: (2009)

Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma
por: Maser, Tyler, et al.
Publicado: (2017)

Discovering Putative Prion-Like Proteins in Plasmodium falciparum: A Computational and Experimental Analysis
por: Pallarès, Irantzu, et al.
Publicado: (2018)

Discovery of γ-Mangostin as an Amyloidogenesis Inhibitor
por: Yokoyama, Takeshi, et al.
Publicado: (2015)

Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage
por: Manral, Pallavi, et al.
Publicado: (2015)

Right inferior frontal cortex activity correlates with tolcapone responsivity in problem and pathological gamblers
por: Kayser, Andrew S., et al.
Publicado: (2016)

Addition of Tolcapone in Intrajejunal Levodopa Infusion Therapy Requires a Pronounced Dose Reduction
por: Schröter, Nils, et al.
Publicado: (2020)

Tolcapone Potently Inhibits Seminal Amyloid Fibrils Formation and Blocks Entry of Ebola Pseudoviruses
por: Qiu, Mengjie, et al.
Publicado: (2020)

Molecular Tweezers Targeting Transthyretin Amyloidosis
por: Ferreira, Nelson, et al.
Publicado: (2014)

Functional Amyloidogenesis and Cytotoxicity—Insights into Biology and Pathology
por: Fowler, Douglas M., et al.
Publicado: (2012)

Prediction and Analysis of Antibody Amyloidogenesis from Sequences
por: Liaw, Chyn, et al.
Publicado: (2013)

Clusterin transduces Alzheimer-risk signals to amyloidogenesis
por: Liu, Xi, et al.
Publicado: (2022)

Catechol-o-methyltransferase inhibitor tolcapone improves learning and memory in naïve but not in haloperidol challenged rats
por: Mihaylova, Anita, et al.
Publicado: (2019)

Tolcapone in Obsessive Compulsive disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial
por: Grant, Jon E., et al.
Publicado: (2021)

Transthyretin chemical chaperoning by flavonoids: Structure–activity insights towards the design of potent amyloidosis inhibitors
por: Ferreira, Nelson, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p4sn6pm53519joupfud2qifnov